Fernandes E Silva, E <br/><br/>
C-phycocyanin to overcome the multidrug resistance phenotype in human erythroleukemias with or without interaction with ABC transporters.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Oct 2018 
 - 532-542 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2018.06.145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Binding Sites<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Daunorubicin--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Multiple--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>K562 Cells<br/>Leukemia, Erythroblastic, Acute--drug therapy<br/>Macrophages, Peritoneal--drug effects<br/>Mice<br/>Molecular Docking Simulation<br/>Multidrug Resistance-Associated Proteins--genetics<br/>Phycocyanin--metabolism<br/>Protein Binding<br/>Protein Conformation<br/>Time Factors<br/>Vincristine--pharmacology